<DOC>
	<DOCNO>NCT00002475</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy work different way stop tumor cell divide stop grow die . Vaccines make patient 's tumor tissue may make body build immune response kill tumor cell . Chemotherapy combine vaccine therapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine cyclophosphamide tumor cell vaccine treat patient metastatic cancer cancer high risk recurrence .</brief_summary>
	<brief_title>Cyclophosphamide Plus Vaccine Therapy Treating Patients With Advanced Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine safety clinical effect autologous allogeneic active-specific intralymphatic immunotherapy vaccine contain interferon alfa interferon gamma-treated tumor cell follow sargramostim ( GM-CSF ) patient advanced cancer . OUTLINE : This pilot study . Patients stratify tumor type . Tumor tissue remove patient incubate interferon alfa interferon gamma 72-96 hour . ( If autologous tumor cell available , allogeneic vaccine prepare . ) Harvested activated cell irradiate immediately prior use . Patients receive cyclophosphamide IV . 48-72 hour cyclophosphamide administration , patient receive tumor cell vaccine intradermally . Patients also receive sargramostim ( GM-CSF ) subcutaneously prior vaccine administration daily next 8 day . Treatment repeat every 2 week 3 course absence unacceptable toxicity . Patients respond stable disease completion course 3 may receive additional course . Patients follow survival . PROJECTED ACCRUAL : A total 20-40 patient accrue study within 18-24 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm cancer amenable cure longterm control surgery , radiotherapy , chemotherapy , hormonal manipulation , include follow tumor type : Colon cancer Lung cancer Renal cancer Breast cancer Pancreatic cancer Metastatic disease subclinical disease high risk recurrence No brain metastasis unresponsive irradiation surgery Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Not specify Menopausal status : Not specify Performance status : ECOG 02 OR Karnofsky 70100 % Life expectancy : At least 3 month Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No prior concurrent significant cardiovascular disease Pulmonary : No prior concurrent pulmonary disease Other : No prior concurrent autoimmune disease No prior concurrent major medical illness HIV negative No clinical evidence AIDS Not pregnant PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics At least 4 week since prior chemotherapy Endocrine therapy : See Disease Characteristics At least 4 week since prior hormonal therapy No concurrent chronic steroid therapy Radiotherapy : See Disease Characteristics At least 4 week since prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage III renal cell cancer</keyword>
	<keyword>stage IV renal cell cancer</keyword>
	<keyword>recurrent renal cell cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>pulmonary carcinoid tumor</keyword>
	<keyword>recurrent malignant mesothelioma</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>